Patients with Pediatric-Onset Immune-Mediated Inflammatory Diseases Have a Four-Times Increased Risk of Dying
The aim of this study was to estimate the effect of pediatric-onset immune-mediated inflammatory diseases on the risk of all-cause and cause-specific mortality to see if there are similar trends in the other disease groups that have been reported for patients with pediatric-onset inflammatory bowel disease. Listen to Sabine Jansson in this MEDtalk about the study that was presented at the ECCO Congress 2024.
